PRF Technologies (PRFX) Income towards Parent Company (2020 - 2025)
PRF Technologies' (PRFX) quarterly Income towards Parent Company came in at $6000.0 in Q2 2025, down 93.88% on a YoY basis from $98000.0 in Q2 2024, and down 93.88% quarter-over-quarter from $98000.0 in Q2 2024.
Powered by 
Analysis
PRF Technologies (PRFX) Income towards Parent Company (2020 - 2025) Analysis & Trends
PRF Technologies (PRFX) has reported Income towards Parent Company for 6 consecutive years, with $6000.0 the latest figure, recorded in Q2 2025.
- For the quarter ending Q2 2025, Income towards Parent Company fell 93.88% year-over-year to $6000.0; the trailing twelve-month figure through Jun 2025 stood at -$9.0 million (up 13.08% YoY), and the FY2025 full-year result was -$5.0 million, up 65.65% from the prior year.
- Income towards Parent Company retreated to $6000.0 in Q2 2025 per PRFX's latest filing, from $98000.0 in the prior quarter.
- Across five years, Income towards Parent Company topped out at $98000.0 in Q2 2024 and bottomed at -$5.6 million in Q1 2024.
- Historically, Income towards Parent Company has averaged -$2.1 million across 5 years, with a median of -$1.8 million in 2022.
- The sharpest annual moves came in 2021 and 2024: Income towards Parent Company tumbled 1444.7% in 2021, then jumped 104.35% in 2024.
- Over 5 years, Income towards Parent Company stood at -$1.7 million in 2021, then plunged by 87.02% to -$3.3 million in 2022, then dropped by 9.46% to -$3.6 million in 2023, then surged by 102.75% to $98000.0 in 2024, then tumbled by 93.88% to $6000.0 in 2025.
- According to Business Quant data, Income towards Parent Company over the past three periods registered $6000.0, $98000.0, and -$5.6 million for Q2 2025, Q2 2024, and Q1 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 46.72 Bn | 43.07 Bn | 2.15 Bn |
| 2 | Viatris | 19.64 Bn | 18.75 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 10.36 Bn | 10.22 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 6.44 Bn | 6.39 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.11 Bn | 1.24 Bn | 2.10 Bn |
| 6 | Ani Pharmaceuticals | 1.88 Bn | 1.52 Bn | 165.89 Mn |
| 7 | Alvotech | 1.83 Bn | 1.69 Bn | 2.56 Mn |
| 8 | Amphastar Pharmaceuticals | 1.04 Bn | 751.07 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 382.22 Mn | 340.97 Mn | 17.15 Mn |
| 10 | PRF Technologies | 622,054.07 | -10.31 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 6,000.00 |
| Jun 30, 2024 | 98,000.00 |
| Mar 31, 2024 | -5.57 Mn |
| Dec 31, 2023 | -3.56 Mn |
| Sep 30, 2023 | -1.35 Mn |
| Jun 30, 2023 | -2.25 Mn |
| Mar 31, 2023 | -2.42 Mn |
| Dec 31, 2022 | -3.26 Mn |
| Sep 30, 2022 | -2.10 Mn |
| Jun 30, 2022 | -1.85 Mn |
| Mar 31, 2022 | -1.67 Mn |
| Dec 31, 2021 | -1.74 Mn |
| Sep 30, 2021 | -1.77 Mn |
| Jun 30, 2021 | -1.66 Mn |
| Mar 31, 2021 | -2.04 Mn |
| Dec 31, 2020 | -691,000.00 |
| Sep 30, 2020 | -700,000.00 |
| Jun 30, 2020 | -148,000.00 |
| Mar 31, 2020 | -132,000.00 |
API Access
PRF Technologies Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=PRFX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "PRFX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=PRFX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();